TY - JOUR AU - E. J. Austin AU - Q. E. O'Brien AU - M. S. Ruiz AU - A. D. Ratzliff AU - E. C. Williams AU - U. Koch A1 - AD - Department of Health Systems and Population Health, School of Public Health, University of Washington, Box 351621, Seattle, WA, 98105, USA. austie@uw.edu.; Department of Clinical Research and Leadership, School of Medicine and Health Sciences, The George Washington University, Washington, D.C, USA. austie@uw.edu.; Department of Prevention and Community Health, Milken Institute School of Public Health, The George Washington University, Washington, D.C, USA. austie@uw.edu.; Department of Clinical Research and Leadership, School of Medicine and Health Sciences, The George Washington University, Washington, D.C, USA.; Department of Prevention and Community Health, Milken Institute School of Public Health, The George Washington University, Washington, D.C, USA.; Department of Psychiatry and Behavioral Sciences, School of Medicine, University of Washington, Seattle, WA, USA.; Advancing Integrated Mental Health Solutions (AIMS) Center, University of Washington, Seattle, WA, USA.; Department of Health Systems and Population Health, School of Public Health, University of Washington, Box 351621, Seattle, WA, 98105, USA.; Center of Innovation for Veteran-Centered and Value-Driven Care, Health Services Research & Development, VA Puget Sound, Seattle, WA, USA. AN - 37668745 BT - Community Ment Health J C5 - Opioids & Substance Use CP - 2 DA - Feb DO - 10.1007/s10597-023-01175-1 DP - NLM ET - 20230905 IS - 2 JF - Community Ment Health J LA - eng PY - 2024 SN - 0010-3853 SP - 330 EP - 339+ ST - Patient and Provider Perspectives on Processes of Engagement in Outpatient Treatment for Opioid Use Disorder: A Scoping Review T1 - Patient and Provider Perspectives on Processes of Engagement in Outpatient Treatment for Opioid Use Disorder: A Scoping Review T2 - Community Ment Health J TI - Patient and Provider Perspectives on Processes of Engagement in Outpatient Treatment for Opioid Use Disorder: A Scoping Review U1 - Opioids & Substance Use U3 - 10.1007/s10597-023-01175-1 VL - 60 VO - 0010-3853 Y1 - 2024 ER -